Influence of Silicate Concentrations on Growth, Carotenoid, and Fatty Acid Profiles of the Marine Diatom Conticribra weissflogii DOI Creative Commons
David Kwame Amenorfenyo, Feng Li, Xiangyu Rui

et al.

Marine Drugs, Journal Year: 2024, Volume and Issue: 22(11), P. 504 - 504

Published: Nov. 6, 2024

Enhancing microalgal growth and bioactive compound production is becoming a duty for improving photosynthetic microorganisms. In this study, the growth, carotenoid, fatty acid profiles of

Language: Английский

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I – composition and production methods DOI
Faezeh Fathi, Tatiane de Oliveira Xavier Machado, Helena de Almeida Cerqueira Kodel

et al.

Expert Opinion on Drug Delivery, Journal Year: 2024, Volume and Issue: 21(10), P. 1479 - 1490

Published: Oct. 2, 2024

Nanoparticles (NPs) are widely used in the pharmaceutical field to treat various human disorders. Among these, lipid-based NPs (LNPs), including solid lipid nanoparticles (SLN) and nanostructured carriers (NLC), favored for drug/bioactive delivery due their high stability, biocompatibility, encapsulation efficiency, sustained/controlled release. These properties make them particularly suitable as of compounds derived from plant sources.

Language: Английский

Citations

6
Fabrication, characterization, stability and re-dispersity of H-aggregates fucoxanthin/whey protein/chitosan nanoparticles DOI
Yingyuan Zhao, Yuting Sun, Yuqing Chen

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 143711 - 143711

Published: April 1, 2025

Language: Английский

Citations

0
Unlocking the Green Gold: Exploring the Cancer Treatment and the Other Therapeutic Potential of Fucoxanthin Derivatives from Microalgae DOI Creative Commons
Fatouma Mohamed Abdoul‐Latif, Ayoub Ainane,

Ibrahim Houmed Aboubaker

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(7), P. 960 - 960

Published: July 18, 2024

Fucoxanthin, a carotenoid widely studied in marine microalgae, is at the heart of scientific research because its promising bioactive properties for human health. Its unique chemical structure and specific biosynthesis, characterized by complex enzymatic conversion organisms, have been examined depth this review. The antioxidant, anti-inflammatory, anti-cancer activities fucoxanthin rigorously supported data from vitro vivo experiments early clinical trials. Additionally, review explores emerging strategies to optimize stability efficacy fucoxanthin, aiming increase solubility bioavailability enhance therapeutic applications. However, despite these potential benefits, challenges persist, such as limited technological obstacles hindering large-scale production. medical exploitation thus requires an innovative approach continuous optimization overcome barriers. Although further needed refine use, offers development natural therapies aimed improving By integrating knowledge about mechanisms action, beneficial effects, future studies could open new perspectives treatment cancer other chronic diseases.

Language: Английский

Citations

3
Influence of Silicate Concentrations on Growth, Carotenoid, and Fatty Acid Profiles of the Marine Diatom Conticribra weissflogii DOI Creative Commons
David Kwame Amenorfenyo, Feng Li, Xiangyu Rui

et al.

Marine Drugs, Journal Year: 2024, Volume and Issue: 22(11), P. 504 - 504

Published: Nov. 6, 2024

Enhancing microalgal growth and bioactive compound production is becoming a duty for improving photosynthetic microorganisms. In this study, the growth, carotenoid, fatty acid profiles of

Language: Английский

Citations

0